Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Biomedicines|October 26, 2024
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of EndometriosisAntonella Ravaggi, Cosetta Bergamaschi, Chiara Galbiati, et al.
Human Reproduction (Oxford, England)|November 21, 2025
Serum miRNA-based diagnostic models for endometriosis: from discovery to validationAntonella Ravaggi, Cosetta Bergamaschi, Jacopo Conforti, et al.
Breast Cancer Research and Treatment|July 20, 2006
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancerGiampietro Gasparini, Massimo Gion, Luigi Mariani, et al.
Clinical Chemistry and Laboratory Medicine|September 10, 2013
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosisElisabetta Bandiera, Laura Zanotti, Aline S C Fabricio, et al.
Gynecologic Oncology|January 24, 2016
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter studyCesare Romagnolo, Antonette E Leon, Aline S C Fabricio, et al.
Clinical Chemistry|October 5, 2012
Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor MarkersGyörgy Sölétormos, Michael J Duffy, Daniel F Hayes, et al.
Journal of Translational Medicine|March 5, 2024
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patientsGiulia Pasello, Aline S C Fabricio, Paola Del Bianco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 10, 2014
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms, , Elisabetta Buscarini, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
Pageof 9